SM

Shailesh Manakchand Goyal

Active Director Designated Partner DIN 10467935
DIN 10467935 First appointment Jan 2024 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Shailesh Manakchand Goyal

Data last updated:

Shailesh Manakchand Goyal is a Designated Partner at Quickstep Pharmaceuticals Llp (since 2024). The company operates in Pharma.

DIN 10467935
Primary Designation Designated Partner
Industry Pharma
First Appointment 17 Jan 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner17 Jan 20242024Active

Board colleagues of Shailesh Manakchand Goyal

NameDINCompanyDesignation
Dimple Bharat Kumar Patel10467936Quickstep Pharmaceuticals LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Quickstep Pharmaceuticals Llp
Premium access

Shareholding and investment profile for Shailesh Manakchand Goyal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shailesh Manakchand Goyal

Shailesh Manakchand Goyal currently holds 1 directorship: Quickstep Pharmaceuticals Llp (Designated Partner, since 17 Jan 2024).

Shailesh Manakchand Goyal was first appointed on 17 Jan 2024 as Designated Partner at Quickstep Pharmaceuticals Llp.

The current boards of Shailesh Manakchand Goyal's companies include Dimple Bharat Kumar Patel (Quickstep Pharmaceuticals Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available